SAPIRSTEIN JAMES 4
4 · First Wave BioPharma, Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
SAPIRSTEIN JAMES
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2023-07-03$1.54/sh−3,349$5,157→ 36,161 total
Footnotes (3)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.49 to $1.61. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes unvested RSUs.